Patricia M. Cousins-Mulrooney
St. John's, NL, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification of antibodies cross-reactive with woodchuck immune cells and activation of virus-specific and global cytotoxic T cell responses by anti-PD-1 and anti-PD-L1 in experimental chronic hepatitis B and persistent occult hepadnaviral infection.
Journal: Frontiers in microbiology
Published: August 03, 2022
Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis.
Journal: Frontiers in microbiology
Published: April 14, 2021
Differential Expression of Woodchuck Toll-Like Receptors 1-10 in Distinct Forms of Infection and Stages of Hepatitis in Experimental Hepatitis B Virus Infection.
Journal: Frontiers in microbiology
Published: September 05, 2018
Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma.
Journal: Oncogenesis
Published: June 21, 2016
Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.
Journal: Journal of clinical and translational hepatology
Published: June 02, 2015
Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis B.
Journal: PLoS pathogens
Published: March 03, 2014
Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: November 21, 2013
Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis.
Journal: Journal of virology
Published: November 09, 2012
Hepatitis C virus load and expression of a unique subset of cellular genes in circulating lymphoid cells differentiate non-responders from responders to pegylated interferon alpha-ribavirin treatment.
Journal: Journal of medical virology
Published: November 05, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026